Dublin, July 27, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Stomach Cancer Forecast in 17 Major Markets 2016-2026" report to their offering.
This report provides the current incident population for Stomach Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Argentina, Australia, Canada, Russian, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight, several of the classifications and co-morbidities of Stomach Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main features and co-morbidities associated with Stomach Cancer include:
- History of stomach polyps or stomach lymphoma
- Family history of stomach cancer
- Colorectal cancer
- Familial adenomatous polyposis
- BRCA1/BRCA2 mutations
- Megaloblastic (pernicious) anaemia or being blood type A
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key Co-morbid Conditions/ Features Associated with the Disease
8. Methodology for Quantification of Patient Numbers
9. Top-Line Incidence for Stomach Cancer
10. Stages and Grading of Stomach Cancer
11. Abbreviations used in the Report
12. Patient-Based Offering
13. Online Pricing Data and Platforms
14. References
15. Appendix
For more information visit http://www.researchandmarkets.com/research/4mkzwn/stomach_cancer